drugset / Trial / NCT01759862

Perioperative Aminophylline to Improve Early Kidney Function After a Kidney Transplant

NCT01759862

Completed 50 enrolled Stanford University
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to evaluate whether peri-transplant administration of a drug named aminophylline to children undergoing a kidney transplant from deceased donors improves early graft function and also projects on long term graft function.

Timeline

Start
2012-11
Primary completion
2017-01-05
Completion
2017-07-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminophylline Small molecule 1.8 mg/kg

Indications

No indication recorded.